Ultra-High-Frequency ECG in Cardiac Pacing and Cardiac Resynchronization Therapy: From Technical Concept to Clinical Application. [PDF]
Nguyên UC+11 more
europepmc +1 more source
Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology [PDF]
R.N.W. Hauer+6 more
openalex +1 more source
Long-Term His-Bundle Pacing and Cardiac Function
Melvin M. Scheinman, Leslie A. Saxon
openalex +1 more source
Reversal of Pacing-Induced Cardiomyopathy Following Cardiac Resynchronization Therapy.
S. Khurshid+9 more
semanticscholar +1 more source
Public preferences regarding slow codes in critical care
Abstract The term slow code refers to an intentional reduction in the pace or intensity of resuscitative efforts during a medical emergency. This can be understood as an intermediate level between full code (full resuscitation efforts) and no code (no resuscitation efforts) and serves as a symbolic gesture when intervention is considered medically ...
Philipp Sprengholz
wiley +1 more source
Wearable sensors in paediatric neurology
Types of signals monitored in children's natural environments using wearable sensors, and their associated applications in various paediatric neurological conditions. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16267 Abstract Wearable sensors have the potential to transform diagnosis, monitoring, and management of children ...
Camila González Barral, Laurent Servais
wiley +1 more source
Temporary transvenous cardiac pacing in cathlab - myocardial infarction versus other causes - differences, complications, and prognosis. Data from a single-center retrospective analysis. [PDF]
Skowerski T+6 more
europepmc +1 more source
A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley +1 more source